Ann Hepatobiliary Pancreat Surg.  2019 Nov;23(4):392-396. 10.14701/ahbps.2019.23.4.392.

The impact of perioperative inotropes on the incidence of pancreatic leak following pancreaticoduodenectomy

• Casey P
• Chaudhury
• Khan A
• Amin J
• Afzal A
• Corallo C
• Sebastian
• Atkinson M
• Subar D

• KMID: 2464330
• DOI: http://doi.org/10.14701/ahbps.2019.23.4.392

Abstract

BACKGROUNDS/AIMS
Pancreatic leak and fistula formation following pancreatic resection is a dreaded complication associated with significant morbidity and mortality. The perioperative use of inotropes has been implicated in anastomotic dehiscence in other types of gastrointestinal surgery but their impact in pancreatic surgery remains unclear and a potentially modifiable risk factor for pancreatic leak. This study aims to assess the impact of perioperative inotrope infusion on the incidence of pancreatic leak following pancreaticoduodenectomy.
METHODS
Retrospective data analysis of all patients undergoing pancreaticoduodenectomy at a tertiary HPB institute. Multivariate analysis and regression models assessed the impact of inotrope use against other known risk factors such as pancreatic duct size and gland texture. Pancreatic fistulae were graded as per ISGPF as Grade A (biochemical leak), Grade B and Grade C fistula.
RESULTS
One-hundred and twenty-three (123) patients were included. A total of 52 patients (42%) developed a leak (29 grade A, 15 grade B, and 8 Grade C). In the fistula group, 28 patients (55%) received perioperative inotropes compared to 26 (35%) in the no fistula group. On univariate analysis, patients receiving inotropes (p=0.04) and patients with a soft pancreatic texture (p=0.003) had a statistically higher incidence of developing a pancreatic fistula of any grade. On multivariate analysis, only inotrope use was associated with an increased risk of developing a pancreatic fistula of any grade (OR 2.46, p=0.026), independent of pancreatic texture and pancreatic duct size.
CONCLUSIONS
Perioperative inotrope use is associated with an increase incidence of pancreatic leak following pancreaticoduodenectomy and should therefore be used judiciously.

Keyword

Pancreatic fistula; Pancreaticodudenectomy; Inotropic agent; Pancreatic cancer

MeSH Terms

Fistula
Humans
Incidence*
Mortality
Multivariate Analysis
Pancreatic Ducts
Pancreatic Fistula
Pancreatic Neoplasms
Pancreaticoduodenectomy*
Retrospective Studies
Risk Factors
Statistics as Topic

Reference

1. Kagedan DJ, Ahmed M, Devitt KS, Wei AC. Enhanced recovery after pancreatic surgery: a systematic review of the evidence. HPB (Oxford). 2015; 17:11–16.

2. Amini N, Spolverato G, Kim Y, Pawlik TM. Trends in hospital volume and failure to rescue for pancreatic surgery. J Gastrointest Surg. 2015; 19:1581–1592.

3. Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000; 232:419–429.

4. Fuks D, Piessen G, Huet E, Tavernier M, Zerbib P, Michot F, et al. Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg. 2009; 197:702–709.

5. Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM Jr. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013; 216:1–14.

6. Laks S, Isaak RS, Strassle PD, Hance L, Kolarczyk LM, Kim HJ. Increased intraoperative vasopressor use as part of an enhanced recovery after surgery pathway for pancreatectomy does not increase risk of pancreatic fistula. J Pancreat Cancer. 2018; 4:33–40.

7. Spronk PE, Zandstra DF, Ince C. Norepinephrine compromises intestinal microvascular perfusion? Intensive Care Med. 2004; 30:173–174. author reply 175.

8. Adanir T, Nazli O, Kara C, Aksun M, Sozutek A, Sencan A, et al. The relationship between vasopressor dose and anastomotic leak in colon surgery: an experimental trial. Int J Surg. 2010; 8:221–224.

9. Choudhuri AH, Uppal R, Kumar M. Influence of non-surgical risk factors on anastomotic leakage after major gastrointestinal surgery: audit from a tertiary care teaching institute. Int J Crit Illn Inj Sci. 2013; 3:246–249.

10. Zakrison T, Nascimento BA Jr, Tremblay LN, Kiss A, Rizoli SB. Perioperative vasopressors are associated with an increased risk of gastrointestinal anastomotic leakage. World J Surg. 2007; 31:1627–1634.

11. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery. 2017; 161:584–591.

12. Hiltebrand LB, Krejci V, Jakob SM, Takala J, Sigurdsson GH. Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock. Anesthesiology. 2007; 106:1156–1167.

13. Zhang W, Shibamoto T, Kuda Y, Shinomiya S, Kurata Y. The responses of the hepatic and splanchnic vascular beds to vasopressin in rats. Biomed Res. 2012; 33:83–88.

14. Sheridan WG, Lowndes RH, Young HL. Tissue oxygen tension as a predictor of colonic anastomotic healing. Dis Colon Rectum. 1987; 30:867–871.

15. Mathur A, Pitt HA, Marine M, Saxena R, Schmidt CM, Howard TJ, et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg. 2007; 246:1058–1064.

16. Gaujoux S, Cortes A, Couvelard A, Noullet S, Clavel L, Rebours V, et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery. 2010; 148:15–23.

17. Bassi C, Falconi M, Molinari E, Mantovani W, Butturini G, Gumbs AA, et al. Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: results of a prospective randomized trial. Surgery. 2003; 134:766–771.

18. Coolsen MM, van Dam RM, van der Wilt AA, Slim K, Lassen K, Dejong CH. Systematic review and meta-analysis of enhanced recovery after pancreatic surgery with particular emphasis on pancreaticoduodenectomies. World J Surg. 2013; 37:1909–1918.

19. Greco M, Capretti G, Beretta L, Gemma M, Pecorelli N, Braga M. Enhanced recovery program in colorectal surgery: a meta-analysis of randomized controlled trials. World J Surg. 2014; 38:1531–1541.